Medical Sodium Citrate PT Tube for Coagulation Testing with 9: 1 Ratio

Name: Medical Sodium Citrate PT Tube for Coagulation Testing with 9: 1 Ratio
Brand: Guizhou Tedia Medical Instruments Co., Ltd.
SKU: 2188020132

Guizhou, ChinaGuizhou Tedia Medical Instruments Co., Ltd.

US$0.05

10,000-49,999 Pieces

US$0.04

50,000-99,999 Pieces

US$0.03

100,000+ Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

Vacuum Blood Tube & Blood Bag

Material

Pet/ Glass

Model NO.

TDYX04

Ethylene Oxide Sterilization

Quality Guarantee Period

Two Years

Group

Adult

Logo Printing

With Logo Printing

Quality Certification

CE/ISO9001/ISO13485/FSC

OEM

Avaliable

Properties

Medical Polymer Materials & Products

Sample

Avaliable

Cap Color

Blue

Transport Package

Carton

Specification

13*75mm

Trademark

Tedia

Origin

Guizhou

HS Code

90183900

Production Capacity

1000000000 Piece/Pieces Per Month

Company profile

Management CertificationProduct CertificationStandardized quality controlHigh Repeat Buyers Choice

Guizhou Tedia Medical Instruments Co., Ltd.

Guizhou, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 7 Years CertifiedNearest Port: Shenzhen Port, Shanghai PortAverage Response Time: ≤5.52h

AI-Powered supplier vetting

SummaryThe supplier demonstrates broad customization, OEM/ODM service, in-stock capability, and established quality and product compliance certifications. It exports 21%–30% of sales and has seven years of export experience, but overseas service coverage is limited: no overseas agents, branches, warehouses, showrooms, or listed service countries. Quality, complaint-handling, corrective-action, and supplier-assessment procedures exist, yet written records are absent in several areas. Production-related evidence includes multiple automated production lines and a stated one-month peak-season fulfillment time, while the lack of a valid manufacturing-capacity contract with affiliated subcontractors is a structural concern. Financial information is limited to year labels without performance values, so credibility cannot be fully assessed. Innovation evidence is mixed: ODM and extensive design services are available, but no new products were reported in the past year and no SDK is available.

Supplier typeThe supplier provides OEM and ODM services, offers extensive customization, maintains in-stock capability, and operates or is associated with multiple production lines including packing, blood vessel collection, blood needle, anticoagulation, bed sheet, and automatic cap assembly lines. However, the absence of a valid manufacturing-capacity contract with affiliated subcontractors indicates a documented production-relationship gap.

CertificationsThe supplier reports an ISO9001:2015 management-system certificate and CE product compliance certification. These are explicit certifications supporting quality-system and product-compliance capability.

After-Sales capabilityService procedures exist for corrective and preventive actions, customer complaints, and supplier-service assessment, but written records are absent. The supplier has no overseas agents, branches, warehouses, showrooms, or listed overseas service countries, although it has attended CMEF and offers stock service.

Production capacityThe supplier reports in-stock capability, multiple automated or specialized production lines, uniform finished-product inspection instructions, and a one-month peak-season lead time. Nevertheless, the absence of a valid contract with affiliated subcontractors is a clear production-management deficiency.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, minor customization, and flexible customization, and also provides ODM services. This indicates a broad and clearly stated customization scope.